TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Solör Bioenergi Holding AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
2,586,000
|
2,128,000
|
1,682,000 |
Financial expenses |
1,228,000
|
666,000
|
423,000 |
Earnings before taxes |
-1,135,000
|
-424,000
|
-328,000 |
EBITDA |
538,000
|
297,000
|
353,000 |
Total assets |
13,518,000
|
13,635,000
|
10,145,000 |
Current assets |
1,243,000
|
1,471,000
|
2,685,000 |
Current liabilities |
1,731,000
|
884,000
|
719,000 |
Equity capital |
-5,014,000
|
-3,383,000
|
-2,952,000 |
- share capital |
402,000
![]() |
402,000
![]() |
402,000 |
Employees (average) |
337
|
310
|
262 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
-37.1%
|
-24.8%
|
-29.1% |
Turnover per employee |
7,674
|
6,865
|
6,420 |
Profit as a percentage of turnover |
-43.9%
|
-19.9%
|
-19.5% |
Return on assets (ROA) |
0.7%
|
1.8%
|
0.9% |
Current ratio |
71.8%
|
166.4%
|
373.4% |
Return on equity (ROE) |
22.6%
|
12.5%
|
11.1% |
Change turnover |
458,000
|
446,000
|
499,000 |
Change turnover % |
22%
|
27%
|
42% |
Chg. No. of employees |
27
|
48
|
56 |
Chg. No. of employees % |
9%
|
18%
|
27% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.